Universal (UVV) Investor Presentation summary

Business overview and market position

• Operates in 40 global markets with over 50 years of expertise in natural health and wellness products, offering 800+ products across six categories.

• Fully integrated model with in-house R&D, procurement, testing, and manufacturing for quality and sustainability.

• Global supplement industry is projected to grow at a 6% CAGR, reaching $214B by 2026, with North America and Asia as key regions.

• 2023 sales distribution: 45% Asia, 31% North America, 18% Europe, 5% Latin America.

• Customers value premium, science-backed products and the brand’s reputation for purity and potency.

Product portfolio and manufacturing

• Diverse offerings include digestive, general health, cardiovascular, immune, sports/energy, and weight management products.

• In-house manufacturing ensures strict quality control, with 600+ tests per formula and multiple certifications (ISO, NSF, USDA Organic, Halal, TGA, GMP).

• State-of-the-art facilities in Utah support R&D and production.

Sales channels and customer engagement

• Sells through an omni-channel platform: direct-to-consumer (web, Amazon), health professionals, specialty retail, and other distributors.

• North America revenue is split among specialty retail (30%), health practitioners (25%), direct-to-consumer (25%), and other (20%).

• Digital-first strategy aims to grow digital sales to over 50% in North America, leveraging proprietary websites, CRM, and subscription programs.

• Subscription program (Subscribe & Thrive) drives recurring revenue, representing 25%+ of North America and 45%+ of Japan orders.